CMMB - Chemomab Therapeutics Ltd. (CMMB) CEO Dale Pfost on Q1 2022 Results - Earnings Call Transcript

Chemomab Therapeutics Ltd. (CMMB) Q1 2022 Earnings Conference Call May 11, 2022 08:00 AM ET Company Participants Barbara Lindheim - Consulting Vice President Investor & Public Relations Dale Pfost - Chairman & CEO David Weiner - Interim CMO Don Marvin - CFO, COO & EVP Adi Mor - Co-Founder & Chief Scientific Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald Jeff Jones - Oppenheimer Nathan Weinstein - Aegis Capital Presentation Operator Greetings and welcome to the Chemomab First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I'd now like to turn the conference over to your host Barbara Lindheim, Consulting Vice President, Strategic Communications for Chemomab. Thank you, you may begin. Barbara Lindheim Welcome to the Chemomab Therapeutics 2022 first-quarter conference call. Thank you for

For further details see:

Chemomab Therapeutics Ltd. (CMMB) CEO Dale Pfost on Q1 2022 Results - Earnings Call Transcript